Wealth manager Escada Partners has lost its lawsuit against two former partners who defected to rival LGT Crestone, with a judge finding a five-year non-compete clause was unreasonable.
An appeals court has set aside a $160,000 judgment against Sydney law firm Atanaskovic Hartnell after finding a “time poor” trial judge had copied and pasted submissions in key parts of his ruling.
A class action against Virgin Australia wants to drag Velocity Rewards into the case, claiming the frequent flyer program was involved in misleading investors about $460 million in funds on Virgin’s balance sheet.
A “time poor” judge’s extensive copying and pasting of submissions and an offensive tweet by senator Pauline Hanson were at the centre of the week’s biggest litigation wins.
A judge has ordered Victoria’s Peninsula Health to fork over $316,260 in penalties for failing to pay overtime to a junior doctor leading a class action, saying the hospital operator had a “highly irresponsible attitude”.
An appeals court has set aside a $160,000 judgment against Sydney law firm Atanaskovic Hartnell, overturning a finding that a founding partner engaged in a “campaign of denigration” against a former general manager.
In a loss for Bed Bath N’ Table, the Full Court has overturned a finding that homewares retailer House engaged in misleading and deceptive conduct by setting up its ‘Bed & Bath’ stores.
The National Anti-Corruption Commission will reconsider investigating six people involved in the Robodebt scheme after a report found commissioner Paul Brereton SC should have done more to remove himself from the decision.
The Queensland government is facing a class action by police officers and staff who faced disciplinary action for refusing to get the COVID-19 vaccine or were vaccinated under protest following a court decision. The class action, funded by billionaire Clive Palmer and run by Alexander Law, was filed in the Supreme Court of Queensland last…
The Commonwealth has argued that a long-running dispute involving drug makers Otsuka, Bristol-Myers Squibb and Generic Health should be put on ice until the High Court rules in a separate matter.